4D Molecular Therapeutics, Inc. (FDMT) Earnings
|
Expand Research on FDMT
| Next EPS Date | 11/11/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -9.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +21.6% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/11/26  |
Q326 | N/A | -$1.04 | N/A | N/A | $3.61M | N/A | N/A | N/A | ||
| 8/13/26 | Q226 | -$1.04 | -$1.01 | -$0.03 | $3.78M | $2.66M | N/A |  | | Details | |
| 8/12/26 |
Q226 | N/A | -$1.01 | N/A | N/A | $2.66M | N/A | N/A | N/A | ||
| 8/6/26 |
Q226 | N/A | -$1.01 | N/A | N/A | $2.66M | N/A | N/A | N/A | ||
| 5/7/26 | Q126 | -$1.01 | -$1.00 | -$0.01 | $3.04M | $3.11M | N/A | | | Details | |
| 3/18/26 |
Q425 | N/A | -$0.53 | N/A | N/A | $26.99M | N/A | N/A | N/A | ||
| 3/17/26 |
Q425 | N/A | -$0.53 | N/A | N/A | $26.99M | N/A | N/A | N/A | ||
| 3/16/26 |
Q425 | N/A | -$0.53 | N/A | N/A | $26.99M | N/A | N/A | N/A |
